P&G Hygiene

When is the next results date for P&G Hygiene?

No Upcoming Board Meetings

Who are the peers of the P&G Hygiene?

P&G Hygiene's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. P&G Hygiene has the lowest 1-year return at -16.17%, while Gillette India leads with 32.82%.

Peers: The peers of P&G Hygiene are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Gillette India, Emami, Hatsun Agro, Bikaji Foods, and Godrej Agrovet.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Hind. Unilever, Godrej Consumer, Hatsun Agro, Bikaji Foods, and Godrej Agrovet. Below Average growth is noted for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Gillette India, Emami, and the rest, while Good growth is seen at Hatsun Agro and Average growth at Bikaji Foods.<BR><BR>Return Snapshot: Gillette India has the highest 1-year return at 32.82%, while P&G Hygiene has the lowest at -16.17%. P&G Hygiene's return is significantly lower than all peers. Additionally, the six-month return is negative for P&G Hygiene, Hind. Unilever, ITC, Godrej Consumer, Emami, and Hatsun Agro.

Who are in the management team of P&G Hygiene?

As of June 2022, the management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, with roles ranging from directors to managing director and chairman.

As of June 2022, the management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>Each member holds a significant role within the company, contributing to its governance and strategic direction.

What does P&G Hygiene do?

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors. As of March 2025, it reported net sales of ₹9,891 Cr and a net profit of ₹1,561 Cr, with a market cap of ₹42,929 Cr.

Overview: <BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling branded packaged fast moving consumer goods in the femcare and healthcare businesses, operating within the FMCG industry and classified as a large-cap company.<BR><BR>History: <BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported are for March 2025, showcasing the company's financial performance.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 9,891 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1,561 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 42,929 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 60.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 1.55% <BR>Debt Equity: -0.83 <BR>Return on Equity: 75.88% <BR>Price to Book: 45.27<BR><BR>Contact Details: <BR>Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099 <BR>Tel: 91-22-28266000 <BR>Email: investorpghh.i@pg.com <BR>Website: http://www.in.pg.com

Who are the top shareholders of the P&G Hygiene?

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

How big is P&G Hygiene?

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, with recent net sales of 4,295.54 Cr and a net profit of 717.65 Cr. Shareholder's funds are 774.86 Cr, and total assets amount to 1,783.69 Cr.

As of 24th July, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 42,511.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 4,295.54 Cr and a Net Profit of 717.65 Cr.<BR><BR>For the latest annual period ending June 2024, Shareholder's Funds amounted to 774.86 Cr, while Total Assets were reported at 1,783.69 Cr.

Is P&G Hygiene technically bullish or bearish?

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

How has been the historical performance of P&G Hygiene?

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

Are Procter & Gamble Hygiene & Health Care Ltd. latest results good or bad?

Procter & Gamble Hygiene & Health Care Ltd. reported strong Q3 FY26 results with a 43.62% increase in net profit quarter-on-quarter, but only 1.10% year-on-year revenue growth raises concerns about sustainability. Despite improved margins and high return on equity, the stock's high valuation and recent decline suggest cautious investor sentiment.

Procter & Gamble Hygiene & Health Care Ltd. has reported mixed results for Q3 FY26. On one hand, the company achieved a net profit of ₹301.46 crore, which reflects a significant increase of 43.62% quarter-on-quarter and 12.24% year-on-year. Additionally, revenue for the quarter reached ₹1,259.91 crore, marking a 9.67% increase from the previous quarter, although the year-on-year growth was modest at just 1.10%.<BR><BR>The operating margin improved to 31.89%, the highest recorded in recent quarters, indicating effective cost management and operational efficiencies. The return on equity (ROE) remains exceptionally high at 81.87%, showcasing strong capital efficiency.<BR><BR>However, despite these positive sequential improvements, the year-on-year revenue growth of only 1.10% raises concerns about the sustainability of the company's growth trajectory. The stock is currently trading at a high P/E ratio of 46 times and a price-to-book value of 41 times, which is significantly above industry averages. This premium valuation, combined with the recent bearish technical indicators and a 20.52% decline from its 52-week high, suggests that investors may be cautious about the stock's future performance.<BR><BR>In summary, while the latest quarterly results show strong sequential performance and profitability, the overall growth concerns and high valuation multiples indicate a challenging environment for the company moving forward.

Should I buy, sell or hold Procter & Gamble Hygiene & Health Care Ltd.?

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share), with an ex-date of February 5, 2026. Despite the significant dividend, total returns have been negative over shorter periods, improving in the long term.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: 05 Feb 26<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the 6-month period, the price return was -14.1%, the dividend return was 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over the 2-year period, the price return was -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>During the 4-year period, the price return was -17.88%, the dividend return was 3.91%, culminating in a total return of -13.97%.<BR><BR>In the 5-year period, the price return was 5.2%, the dividend return was 7.14%, resulting in a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a trend of negative performance, particularly in the shorter time frames, with a more favorable outcome in the longer term.

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share) with an ex-date of August 28, 2025. Despite this, the company has experienced negative total returns over the past 1 to 4 years, though it showed a positive return of 12.34% over the last 5 years.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: Aug-28-2025<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>Over the past 3 months, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the last 6 months, the price return decreased by -14.1%, with a dividend return of 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over 2 years, the price return fell by -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>For the 4-year period, the price return decreased by -17.88%, with a dividend return of 3.91%, resulting in a total return of -13.97%.<BR><BR>In the 5-year span, the price return increased by 5.2%, the dividend return was 7.14%, leading to a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the shorter terms, with negative returns dominating. However, the 5-year period shows a positive total return, suggesting potential recovery or growth in the long term.

Which are the latest news on P&G Hygiene?

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 13-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a stock price decline to 10,564.45, reflecting a -2.46% change. This drop is due to hitting a new 52-week low, underperforming its sector, and weak long-term growth prospects, indicating bearish sentiment among investors.

As of 13-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,564.45, which reflects a change of -265.9 or -2.46%. This drop can be attributed to several factors highlighted in the data. <BR><BR>Firstly, the stock has recently hit a new 52-week low of Rs. 10,499, indicating a significant decrease in value. Performance today shows that the stock has underperformed its sector by -1.77%, and it has fallen after three consecutive days of gains, suggesting a reversal in trend. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish sentiment among investors.<BR><BR>In terms of broader performance, the stock has shown consistent underperformance against the benchmark, with a -21.15% return over the past year, compared to a +1.00% return for the Sensex. Over the last three years, the stock has also lagged behind the BSE500, further indicating a lack of investor confidence. <BR><BR>While there are some positive indicators, such as high management efficiency and recent growth in net sales and profit after tax, these have not been sufficient to offset the negative sentiment surrounding the stock. The company's long-term growth prospects appear poor, with net sales growing at an annual rate of only 5.52% over the last five years, and a high price-to-book value ratio of 36.8 suggests that the stock may be overvalued compared to its peers.<BR><BR>Overall, the combination of hitting a new low, underperformance against benchmarks, and weak long-term growth prospects are contributing to the decline in Procter & Gamble Hygiene & Health Care Ltd.'s stock price.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 14-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a stock price decline to 10,564.45, down 2.46%. This decline is due to hitting a new 52-week low, underperforming against benchmarks, and poor long-term growth prospects despite some recent positive financial results.

As of 14-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,564.45, reflecting a change of -265.9 (-2.46%). This drop can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has recently hit a new 52-week low of Rs. 10,499, indicating a significant decrease in value. The performance today shows that it has underperformed its sector by -1.77%, and it has fallen after three consecutive days of gains, suggesting a reversal in trend. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend.<BR><BR>From a broader perspective, the stock has consistently underperformed against the benchmark indices over the past year, generating a return of -21.15% compared to a +1.00% return from the Sensex. Over the last three years, the stock has also shown a decline of -22.09%, while the benchmark has increased by +28.03%. This consistent underperformance raises concerns among investors.<BR><BR>Moreover, despite some positive financial results, such as a 25.26% growth in PAT for the nine months ending December and record net sales, the long-term growth outlook appears poor. The annual growth rates for net sales and operating profit over the last five years are only 5.52% and 5.34%, respectively. The company's high Price to Book Value ratio of 36.8, coupled with a PEG ratio of 2, suggests that the stock may be overvalued relative to its growth prospects.<BR><BR>In summary, the combination of hitting a new low, underperformance against benchmarks, and poor long-term growth prospects contributes to the decline in Procter & Gamble Hygiene & Health Care Ltd.'s stock price.

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 15-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a stock price decline to 10,564.45, down 2.46%. This drop is due to underperformance against its sector and benchmark, a new 52-week low, and poor long-term growth prospects despite some positive indicators.

As of 15-Mar, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 10,564.45, which reflects a change of -265.9 (-2.46%). This drop is attributed to several factors highlighted in the recent performance data. The stock has hit a new 52-week low of Rs. 10,499 today, indicating a significant decrease in value. Additionally, the stock has underperformed its sector by 1.77% and has fallen after three consecutive days of gains, suggesting a reversal in trend.<BR><BR>Over the past week, the stock has decreased by 2.87%, and its year-to-date performance shows a decline of 18.35%, which is worse than the benchmark Sensex's decline of 12.50%. The stock has consistently underperformed against the benchmark over the last three years, with a one-year return of -21.15% compared to a positive return of 1.00% for the Sensex.<BR><BR>Moreover, the stock is trading below its moving averages across various time frames, indicating a bearish trend. Despite some positive indicators such as high management efficiency and low debt levels, the long-term growth prospects appear poor, with net sales and operating profit growing at only 5.52% and 5.34% annually over the last five years, respectively. The company's high price-to-book value ratio of 36.8 further suggests an expensive valuation, contributing to the stock's decline. Overall, these factors combined have led to the current fall in the stock price of Procter & Gamble Hygiene & Health Care Ltd.